Credential Qtrade Securities’s Oncolytics Biotech ONCY Stock Holding History

Credential Qtrade Securities’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$55	Buy	+52	New	+$58	﹤0.01%	378

Other funds holding ONCY

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Credential Qtrade Securities's ONCY Position: Q1 2024 in Review

Credential Qtrade Securities opened a new position in Oncolytics Biotech (ONCY) in Q1 2024: 52 shares worth $55. The stake represents ﹤0.01% of the portfolio and ranks #378 among its holdings.

36 funds tracked by Wall St. Rank hold ONCY as of Q1 2024.

Credential Qtrade Securities held 52 shares of Oncolytics Biotech worth $55 as of Q1 2024.
Oncolytics Biotech was a new Credential Qtrade Securities position in Q1 2024.
Oncolytics Biotech made up ﹤0.01% of Credential Qtrade Securities's portfolio in Q1 2024, its #378 holding.
36 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2024.

Based on Credential Qtrade Securities's 13F filing for Q1 2024, filed 21 Jul 2025.